New 2-halo-pyridines, their production and pharmaceutical compositions
申请人:LACER, S.A.
公开号:EP0032516B1
公开(公告)日:1984-05-02
US4614833A
申请人:——
公开号:US4614833A
公开(公告)日:1986-09-30
US4736037A
申请人:——
公开号:US4736037A
公开(公告)日:1988-04-05
[EN] HETEROCYCLODIAZEPINE CANNABINOID RECEPTOR MODULATORS FOR TREATMENT OF DISEASE<br/>[FR] MODULATEURS DES RÉCEPTEURS CANNABINOÏDES À BASE D' HÉTÉROCYCLODIAZÉPINE POUR TRAITER UNE MALADIE
申请人:KALYPSYS INC
公开号:WO2009032754A2
公开(公告)日:2009-03-12
The present invention relates to compounds and methods useful as modulators of CB2 for the treatment or prevention of disease states including, but not limited to pain, autoimmune disease, malabsorption syndrome, pulmonary disease, osteoporosis, muscle spasm in cancer, neuromuscular disorder, and atherosclerosis progression.
Synthesis and fungicidal activity of 1,1-diaryl tertiary alcohols
and some of their dehydration derivatives were designed, synthesized and evaluated for their antifungal activities. Some compounds exhibited moderate inhibitory activities against seven plant pathogens at 50μg/mL in vitro, compounds 5g and 7c displayed nearly the same or higher fungicidalactivities against some certain plant pathogens compared with the lead compound pyrimorph. A qualitative structure-activity